| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Andrea Schneider
|
|
|
|
23 |
11 |
p. 1082
|
artikel
|
| 2 |
A new era of drug discovery for amyotrophic lateral sclerosis
|
Andrews, Jinsy A
|
|
|
23 |
11 |
p. 1070-1072
|
artikel
|
| 3 |
A new standard for thrombolysis in acute ischaemic stroke
|
Palaiodimou, Lina
|
|
|
23 |
11 |
p. 1064-1065
|
artikel
|
| 4 |
Changing multiple-sclerosis-induced thoughts and behaviours
|
Beckerman, Heleen
|
|
|
23 |
11 |
p. 1067-1068
|
artikel
|
| 5 |
Changing the landscape of neurological education
|
Sveikata, Lukas
|
|
|
23 |
11 |
p. 1078-1079
|
artikel
|
| 6 |
CNS disease associated with enhanced type I interferon signalling
|
Crow, Yanick J
|
|
|
23 |
11 |
p. 1158-1168
|
artikel
|
| 7 |
Comparative effectiveness of cognitive behavioural therapy, modafinil, and their combination for treating fatigue in multiple sclerosis (COMBO-MS): a randomised, statistician-blinded, parallel-arm trial
|
Braley, Tiffany J
|
|
|
23 |
11 |
p. 1108-1118
|
artikel
|
| 8 |
Correction to Lancet Neurol 2024; 23: 1086
|
|
|
|
23 |
11 |
p. e14
|
artikel
|
| 9 |
Dealing with the reproducibility crisis in neuroscience from the grassroots
|
Mehta, Arpan R
|
|
|
23 |
11 |
p. 1079
|
artikel
|
| 10 |
Dementia-related stigma is still pervasive
|
The Lancet Neurology,
|
|
|
23 |
11 |
p. 1063
|
artikel
|
| 11 |
Equitable access to levetiracetam for people with epilepsy
|
Sen, Arjune
|
|
|
23 |
11 |
p. 1076-1077
|
artikel
|
| 12 |
Evobrutinib in multiple sclerosis: challenges and unmet goals
|
van der Walt, Anneke
|
|
|
23 |
11 |
p. 1068-1070
|
artikel
|
| 13 |
Frailty for neurologists: perspectives on how frailty influences care planning
|
Canevelli, Marco
|
|
|
23 |
11 |
p. 1147-1157
|
artikel
|
| 14 |
Head impacts in elite professional football: a growing concern
|
Martín-Izquierdo, Irina
|
|
|
23 |
11 |
p. 1083-1084
|
artikel
|
| 15 |
Jules Froment's neurological statuettes
|
Ardaillon, Hugo
|
|
|
23 |
11 |
p. 1079-1080
|
artikel
|
| 16 |
Learning to be an adult with a disability
|
Morgan, Jules
|
|
|
23 |
11 |
p. 1086
|
artikel
|
| 17 |
Looking beyond the neurological diagnosis: considering frailty
|
Stoessl, A Jon
|
|
|
23 |
11 |
p. 1072-1073
|
artikel
|
| 18 |
Multidisciplinary care for rare neurological diseases in China
|
Chen, Xin-Yuan
|
|
|
23 |
11 |
p. 1076
|
artikel
|
| 19 |
Neurology crisis in Ethiopia: imbalances in training and retention
|
Gebresilassie, Blen M
|
|
|
23 |
11 |
p. 1077-1078
|
artikel
|
| 20 |
On how a brain beholds beauty
|
Araújo, Rui
|
|
|
23 |
11 |
p. 1085
|
artikel
|
| 21 |
Rustam Al-Shahi Salman: balancing depth and breadth with intracerebral haemorrhage
|
Thorley, Jennifer
|
|
|
23 |
11 |
p. 1081
|
artikel
|
| 22 |
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials
|
Montalban, Xavier
|
|
|
23 |
11 |
p. 1119-1132
|
artikel
|
| 23 |
Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial
|
Pal, Suvankar
|
|
|
23 |
11 |
p. 1097-1107
|
artikel
|
| 24 |
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial
|
Koch, Jan C
|
|
|
23 |
11 |
p. 1133-1146
|
artikel
|
| 25 |
Supporting young carers across neurological disorders
|
Kavanaugh, Melinda S
|
|
|
23 |
11 |
p. 1082
|
artikel
|
| 26 |
Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial
|
Muir, Keith W
|
|
|
23 |
11 |
p. 1087-1096
|
artikel
|
| 27 |
Trial designs for motor neuron disease in the 21st century
|
Vucic, Steve
|
|
|
23 |
11 |
p. 1065-1066
|
artikel
|
| 28 |
Type I interferonopathies with CNS symptoms
|
Mani, Shyamala
|
|
|
23 |
11 |
p. 1073-1075
|
artikel
|
Tijdschrift beschrijving